A detailed history of Russell Investments Group, Ltd. transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 104,118 shares of SAGE stock, worth $596,596. This represents 0.0% of its overall portfolio holdings.

Number of Shares
104,118
Previous 116,334 10.5%
Holding current value
$596,596
Previous $1.26 Million 40.62%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$7.02 - $13.08 $85,756 - $159,785
-12,216 Reduced 10.5%
104,118 $750,000
Q2 2024

Aug 08, 2024

BUY
$10.58 - $17.9 $792,886 - $1.34 Million
74,942 Added 181.05%
116,334 $1.26 Million
Q1 2024

May 08, 2024

SELL
$18.62 - $26.95 $349,087 - $505,258
-18,748 Reduced 31.17%
41,392 $775,000
Q4 2023

Feb 05, 2024

BUY
$17.1 - $22.26 $629,741 - $819,769
36,827 Added 157.97%
60,140 $1.3 Million
Q3 2023

Nov 13, 2023

BUY
$16.75 - $48.98 $378,533 - $1.11 Million
22,599 Added 3165.13%
23,313 $479,000
Q2 2023

Aug 10, 2023

BUY
$40.65 - $59.54 $813 - $1,190
20 Added 2.88%
714 $33,000
Q1 2023

May 09, 2023

BUY
$37.27 - $46.57 $3,093 - $3,865
83 Added 13.58%
694 $29,000
Q2 2022

Jul 29, 2022

SELL
$27.52 - $37.99 $855,982 - $1.18 Million
-31,104 Reduced 98.07%
611 $19,000
Q1 2022

May 05, 2022

SELL
$30.71 - $45.71 $1.64 Million - $2.44 Million
-53,389 Reduced 62.73%
31,715 $1.05 Million
Q4 2021

Jan 21, 2022

SELL
$37.06 - $47.11 $99,802 - $126,867
-2,693 Reduced 3.07%
85,104 $3.63 Million
Q3 2021

Nov 08, 2021

BUY
$40.26 - $57.37 $1.86 Million - $2.65 Million
46,259 Added 111.37%
87,797 $3.89 Million
Q2 2021

Aug 04, 2021

SELL
$54.88 - $79.29 $157,340 - $227,324
-2,867 Reduced 6.46%
41,538 $2.35 Million
Q1 2021

May 10, 2021

SELL
$70.65 - $96.76 $4.27 Million - $5.85 Million
-60,443 Reduced 57.65%
44,405 $3.31 Million
Q4 2020

Feb 08, 2021

BUY
$58.41 - $89.06 $1,985 - $3,028
34 Added 0.03%
104,848 $9.09 Million
Q3 2020

Nov 09, 2020

BUY
$41.13 - $62.45 $406,981 - $617,942
9,895 Added 10.42%
104,814 $6.39 Million
Q2 2020

Aug 05, 2020

BUY
$25.95 - $43.15 $1.51 Million - $2.51 Million
58,268 Added 158.98%
94,919 $3.95 Million
Q1 2020

May 06, 2020

BUY
$26.15 - $77.24 $871,161 - $2.57 Million
33,314 Added 998.32%
36,651 $1.06 Million
Q4 2019

Jan 29, 2020

SELL
$60.18 - $154.77 $95,084 - $244,536
-1,580 Reduced 32.13%
3,337 $240,000
Q3 2019

Nov 01, 2019

BUY
$140.29 - $189.96 $382,430 - $517,830
2,726 Added 124.42%
4,917 $690,000
Q2 2019

Aug 09, 2019

SELL
$157.85 - $183.09 $16,732 - $19,407
-106 Reduced 4.61%
2,191 $401,000
Q1 2019

May 13, 2019

SELL
$89.33 - $163.65 $17 Million - $31.1 Million
-190,067 Reduced 98.81%
2,297 $365,000
Q4 2018

Feb 11, 2019

SELL
$81.94 - $139.71 $111,930 - $190,843
-1,366 Reduced 0.71%
192,364 $18.3 Million
Q3 2018

Oct 26, 2018

BUY
$138.11 - $169.04 $9.8 Million - $12 Million
70,962 Added 57.8%
193,730 $27.3 Million
Q2 2018

Aug 08, 2018

BUY
$140.36 - $175.76 $4.03 Million - $5.04 Million
28,677 Added 30.48%
122,768 $19.1 Million
Q1 2018

May 11, 2018

SELL
$152.15 - $192.33 $1.66 Million - $2.1 Million
-10,912 Reduced 10.39%
94,091 $15.2 Million
Q4 2017

Feb 06, 2018

BUY
$60.72 - $167.34 $4.4 Million - $12.1 Million
72,473 Added 222.79%
105,003 $17.5 Million
Q3 2017

Nov 07, 2017

BUY
$61.4 - $88.52 $2 Million - $2.88 Million
32,530
32,530 $2.03 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $340M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.